Biocept has appointed Michael Terry to the newly created position of senior vice president of commercial operations, where he will lead the company's commercial organization and oversee its business development initiatives. Prior to joining Biocept, Terry served as executive vice president of commercial operations and corporate development at liquid biopsy firm Trovagene. He has also served as executive vice president of Sequenom as CEO of neonatal diagnostics startup Ligand Dx, and has worked for Lumenis, GE Healthcare, and Aspect Medical Systems, among others.
MolecularMD has appointed Frederick Eibel as senior vice president and chief marketing officer. Eibel joins MolecularMD from Wren Laboratories, where he served as senior vice president. Before his time at Wren, Eibel spent 23 years at Roche Diagnostics in various roles. He has also held leadership roles at Rain Dance Technologies, Sequenom, Life Technologies, and Gen Probe.
Almac Diagnostics has appointed Leeona Galligan as VP of UK Operations. She will be responsible for all UK-based operations, including commercial biomarker discovery, CLIA/FDA compliant analytical validation, downstream clinical testing, manufacturing and shipping of clinical specimens, and release of controls and reagents for registrational clinical trials. Galligan joined Almac in September 2009 as a senior scientist. She was appointed clinical testing laboratory manager in 2012 and was subsequently promoted to head of UK lab-based operations.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.